Contract Research
Total Trials
9
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,136
NCT03845959
A Trial of TD0019 in Treatment of Cervical Scapulohumeral Syndrome
Phase: Phase 2
Role: Collaborator
Start: Aug 30, 2017
Completion: Feb 20, 2018
NCT03395028
GCSF Adjunct Therapy for Biliary Atresia
Phase: Early Phase 1
Start: Jan 15, 2018
Completion: Jan 31, 2020
NCT03845348
To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases
Phase: Phase 3
Start: May 22, 2019
Completion: Jun 30, 2023
NCT06657495
To Evaluate the Safety and Efficacy of TD0015 Pilulae in Patients with Knee Osteoarthritis
Start: Jul 1, 2021
Completion: Nov 30, 2024
NCT05042141
Safety and Efficacy of KOVIR in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR)
Phase: N/A
Start: Jul 28, 2021
Completion: Sep 12, 2021
NCT05044650
Efficacy of KOVIR Capsule in the Combination Regimen With Background Treatment in COVID-19 Patients
Start: Jun 30, 2022
Completion: Jun 30, 2022
NCT04373941
Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
Start: Sep 1, 2023
Completion: Oct 31, 2025
NCT07032558
Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions
Phase: Phase 1
Start: Sep 20, 2025
Completion: Oct 25, 2025
NCT07060209
Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults
Completion: Nov 25, 2025
Loading map...